Modified release metronidazole for the treatment of pouchitis after colectomy with ileo-anal pouch anastomosis for ulcerative colitis: a pharmacokinetic study

Registry ID

EUCTR2009-015136-14

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

FORMAC Pharmaceuticals NV

Start date

2009-11-13

Last update

2026-08-16

Conditions

• Pouchitis

Summary

To investigate the pharmacokinetics of two dosages of a modified release formulation of metronidazole in subjects with active acute or chronic pouchitis and compare it to the current standard immediate release formulation of metronidazole (Flagyl 500 mg).

Locations

• , , Belgium

Related clinical trials

• Rifaximin for the Secondary Prevention of Recurrent Pouchitis
• A Study to Learn About the Safety of Vedolizumab and How Well it Works in Children and Teenagers With Active Chronic Pouchitis
• Etrasimod as Prevention of Pouchitis
• GUselkumAb inteRvention and DIet evaluAtioN for Pouchitis
• Mirikizumab in the Treatment of Chronic Inflammatory Conditions of the Pouch
• Fecal Microbiota Transplant for Patients With Chronic Pouchitis

View on source registry